This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Advanced Protein Technologies Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yeon Ji Kim: Innovator in Muscle Health
Introduction
Yeon Ji Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of health and nutrition, particularly in the area of muscular health. His innovative approach focuses on preventing and treating muscular atrophy and sarcopenia.
Latest Patents
Yeon Ji Kim holds a patent for a method aimed at ameliorating, preventing, or treating muscular atrophy or sarcopenia. The patent, titled "Method for ameliorating, preventing or treating muscular atrophy or sarcopenia by administering composition comprising 2'-fucosyllactose as active ingredient," discloses a method that involves administering a composition containing 2'-fucosyllactose (2′-FL) to individuals in need. This composition is designed to enhance mitochondrial function and biosynthesis while reducing the expression of genes associated with muscular atrophy, thereby strengthening muscles and preventing related conditions.
Career Highlights
Yeon Ji Kim is affiliated with Advanced Protein Technologies Corporation, where he continues to develop innovative solutions for muscle health. His work has garnered attention for its potential impact on improving the quality of life for individuals suffering from muscle-related conditions.
Collaborations
Some of his notable coworkers include Jong Won Yoon and Seon Min Jeon, who contribute to the collaborative efforts at Advanced Protein Technologies Corporation.
Conclusion
Yeon Ji Kim's innovative work in the field of muscular health highlights the importance of research and development in combating conditions like muscular atrophy and sarcopenia. His contributions are paving the way for new treatments that can significantly enhance the well-being of individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile